Distribution of calponin and smooth muscle myosin heavy chain in fine- needle aspiration biopsies of the breast

Diagnostic Cytopathology

Volumn 20, Issue 4, 1999, Pages 203-207

  Dabbs, David J ^a   Gown, Allen M ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b PHENOPATH LABORATORIES   (United States)

Author keywords

Breast FNAB; Calponin; Myoepithelial cells; Smooth muscle myosin heavy chain

Indexed keywords

CALPONIN; MYOSIN HEAVY CHAIN;

ADIPOSE TISSUE CELL; ARTICLE; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CARCINOMA; BREAST FIBROADENOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MYOEPITHELIUM CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STROMA CELL;

BIOPSY, NEEDLE; BREAST; BREAST DISEASES; CALCIUM-BINDING PROTEINS; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROFILAMENT PROTEINS; MUSCLE, SMOOTH; MYOSIN HEAVY CHAINS; STROMAL CELLS;

EID: 0032908134     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199904)20:4<203::AID-DC4>3.0.CO;2-V     Document Type: Article

References (26)

1. Layfield LJ. Can fine needle aspiration replace open biopsy in the diagnoses of palpable breast lesions? Am J Clin Pathol 1992;98:145-147.
2. Dabbs DJ. Role of nuclear grading of breast carcinomas in fine needle aspiration specimens. Acta Cytol 1994;38:923-926.
3. Dabbs DJ, Silverman JF. Prognostic factors from the fine-needle aspiration: breast carcinoma nuclear grade. Diagn Cytopathol 1994;10: 203-208.
4. Sneige N. Nuclear grading in fine needle aspirates of the breast. Cytopathol Annu 1992;2:161-172.
5. Zajicek J, Caspersson T, Jakobsson P, et al. Cytologic diagnosis of mammary tumors from aspiration biopsy smears. Comparison of cytologic and histologic findings in 2111 lesions and diagnostic use of cytophotometry. Acta Cytol 14;1970:370-376.
6. Silverman JF, Masood S, Ducatman BS, Wang HH, Sneige N. Can FNA biopsy separate atypical hyperplasia, carcinoma in situ, and invasive carcinoma of the breast? Cytomorphologic criteria and limitations in diagnosis. Diagn Cytopathol 1993;9:713-728.
7. Masood S, Sim SJ, Lu L. Immunohistochemical differentiation of atypical hyperplasia versus carcinoma in situ of the breast. Cancer Detect Prev 1992;16:225-235.
8. Masood S, Frykberg ER, McLellan GL, Dee S, Bullard JB. Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fine-needle aspirates. Diagn Cytopathol 1991;7:581-590.
9. Bondeson L, Lindholm K. Prediction of invasiveness by aspiration cytology applied to nonpalpable breast carcinoma and tested in 300 cases. Diagn Cytopathol 1997;17:315-320.
10. Gown AM, deWever N, Battifora H. Microwave based antigenic unmasking: a revolutionary and new technique for routine immunohistochemistry. Appl Immunohistochem 1993;1:256-266.
11. Ahmed A. The myoepithelium in human breast carcinoma. J Pathol 1974;113:129-135.
12. Bussolati G, Botta G, Bugliotta P. Actin rich (myoepithelial) cells in ductal carcinoma in situ of the breast. Virchows Arch [B] 1980;34:251-259.
13. Bussolati G. Actin rich (myoepithelial) cells in lobular carcinoma in situ of the breast. Virchows Arch [B] 1980;32:165-176.
14. Bussolati G, Botto-Micca FB, Eusebi V, Betts CM. Myoepithelial cells in lobular carcinoma in situ of the breast: a parallel immunocytochemical and ultrastructural study. Ultrastruct Pathol 1981;2:219-230.
15. Gould VE, Jao W, Battifora H. Ultrastructural analysis and a differential diagnosis of breast tumors: the significance of myoepithelial cells, basal lamina, intracytoplasmic lumina and secretory granules. Pathol Res Pract 1980;167:45-70.
16. Gusterson BA, Warburton MJ, Mitchell D, Ellison M, Nevill AM, Rudland PS. Distribution of myoepithelial cells and basement membrane proteins in a normal breast and in benign and malignant breast diseases. Cancer Res 1982;42:4753-4760.
17. Gliotta P, Sapino A, Macr'i L, Skalli O, Gabbiani G, Bussolati G. Specific demonstration of myoepithelial cells by anti-alpha smooth muscle actin antibody. J Histochem Cytochem 1988;36:659-663.
18. Gottlieb C, Raju U, Greenwald KA. Myoepithelial cells and a differential diagnosis of complex benign and malignant breast lesions; an immunohistochemical study. Mod Pathol 1990;3:135-140.
19. Raymond WA, Leong AS. Assessment of invasion in breast lesions using antibodies to basement membrane components and myoepithelial cells. Pathology 1991;23:291-297.
20. Rudland PS, Leinster SJ, Winstanley J, Green B, Atkinson M, Zakhour HD. Immunocytochemical identification of cell types in benign and malignant breast diseases: variations in cell markers accompanying the malignant state. J Histochem Cytochem 1993;41:543-553.
21. Bocker W, Bier B, Freytag G, et al. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha smooth muscle actin, vimentin, collagen IV and laminin. Part I. Normal breast and benign proliferative lesions. Virchows Arch [A] 1992;421:315-322.
22. Bocker W, Bier B, Freytag G, et al. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha smooth muscle actin, vimentin, collagen IV and laminen. Part II. Epitheliosis and ductal carcinoma in situ. Virchows Arch [A] 1992;421:323-330.
23. Eddinger TJ, Murphy RA. Developmental changes in actin and myosin heavy chain isoform expression in smooth muscle. Arch Biochem Biophys 1991;284:232-237.
24. Darby I, Skalli O, Gabbiani G. Alpha smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990;63:21-29.
25. Skalli O, Schurch W, Seemayer T, et al. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filaments proteins. Lab Invest 1989;60:275-285.
26. Wang NP, Wan BC, Skelly M, Frid MG, Glukhova MA, Kotelianski VE, Gown AM. Antibodies to novel myoepithelium-associated proteins distinguish benign lesions and carcinoma in situ from invasive carcinoma of the breast. Appl Immunohistochem 1997;5:141-151.